Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Inhibitory Effect of New Semisynthetic Usnic Acid Derivatives on Human Tyrosyl-DNA Phosphodiesterase 1. / Dyrkheeva, Nadezhda; Luzina, Olga; Filimonov, Aleksandr и др.
в: Planta Medica, Том 85, № 2, 01.01.2019, стр. 103-111.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Inhibitory Effect of New Semisynthetic Usnic Acid Derivatives on Human Tyrosyl-DNA Phosphodiesterase 1
AU - Dyrkheeva, Nadezhda
AU - Luzina, Olga
AU - Filimonov, Aleksandr
AU - Zakharova, Olga
AU - Ilina, Ekaterina
AU - Zakharenko, Alexandra
AU - Kuprushkin, Maxim
AU - Nilov, Dmitry
AU - Gushchina, Irina
AU - Švedas, Vytas
AU - Salakhutdinov, Nariman
AU - Lavrik, Olga
N1 - Publisher Copyright: © 2019 Georg Thieme Verlag. All rights reserved.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Usnic acid, a lichen secondary metabolite produced by a whole number of lichens, has attracted the interest of researchers owing to its broad range of biological activity, including antiviral, antibiotic, anticancer properties, and it possessing a certain toxicity. The synthesis of new usnic acid derivatives and the investigation of their biological activity may lead to the discovery of compounds with better pharmacological and toxicity profiles. In this context, a series of new usnic acid derivatives comprising a terpenoid moiety were synthesized, and their ability to inhibit the catalytic activity of the human DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 was investigated. The most potent compounds (15a, 15b, 15g, and 16a, 16b, 16g) had IC 50 values in the range of 0.33-2.7 μM. The inhibitory properties were mainly dependent on the flexibility and length of the terpenoid moiety, but not strongly dependent on the configuration of the asymmetric centers. The synthesized derivatives showed low cytotoxicity against human cell lines in an MTT assay. They could be used as a basis for the development of more effective anticancer therapies when combined with topoisomerase 1 inhibitors.
AB - Usnic acid, a lichen secondary metabolite produced by a whole number of lichens, has attracted the interest of researchers owing to its broad range of biological activity, including antiviral, antibiotic, anticancer properties, and it possessing a certain toxicity. The synthesis of new usnic acid derivatives and the investigation of their biological activity may lead to the discovery of compounds with better pharmacological and toxicity profiles. In this context, a series of new usnic acid derivatives comprising a terpenoid moiety were synthesized, and their ability to inhibit the catalytic activity of the human DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 was investigated. The most potent compounds (15a, 15b, 15g, and 16a, 16b, 16g) had IC 50 values in the range of 0.33-2.7 μM. The inhibitory properties were mainly dependent on the flexibility and length of the terpenoid moiety, but not strongly dependent on the configuration of the asymmetric centers. The synthesized derivatives showed low cytotoxicity against human cell lines in an MTT assay. They could be used as a basis for the development of more effective anticancer therapies when combined with topoisomerase 1 inhibitors.
KW - Tdp1 inhibitor
KW - terpenophenols
KW - tyrosyl-DNA phosphodiesterase 1
KW - Usnea barbata
KW - Usneaceae
KW - usnic acid
KW - Phosphoric Diester Hydrolases/drug effects
KW - Escherichia coli
KW - Humans
KW - MCF-7 Cells/drug effects
KW - HEK293 Cells/drug effects
KW - Benzofurans/chemical synthesis
KW - Cell Line, Tumor/drug effects
KW - Microorganisms, Genetically-Modified
KW - Phosphodiesterase Inhibitors/chemistry
KW - Molecular Docking Simulation
KW - REPAIR
KW - BIOLOGICAL EVALUATION
KW - ASSAY
KW - CRYSTAL-STRUCTURE
KW - VANADATE
KW - I INHIBITORS
KW - ANTICANCER
KW - GENE
KW - TDP1
KW - BINDING
UR - http://www.scopus.com/inward/record.url?scp=85060375336&partnerID=8YFLogxK
U2 - 10.1055/a-0681-7069
DO - 10.1055/a-0681-7069
M3 - Article
C2 - 30142660
AN - SCOPUS:85060375336
VL - 85
SP - 103
EP - 111
JO - Planta Medica
JF - Planta Medica
SN - 0032-0943
IS - 2
ER -
ID: 18295205